Bjorn Odlander, Managing Director at HealthCap, Stockholm, Stockholms Lan, Sweden — verified investor profile. See contact routes.
Björn Odlander, co-founder and Managing Partner of HealthCap, invests in life sciences companies developing breakthrough therapies for diseases with high unmet medical needs, such as rare diseases, oncology, and genetic disorders. His primary focus is on the Series B stage with check sizes ranging from $100K to $5M, including a $1.5M sweet spot, though HealthCap often invests very early, with about half of its portfolio companies being co-founded by the firm. Notable portfolio companies include Oncopeptides, Fusion Pharmaceuticals, Ultragenyx, and Oncorena, reflecting a distinctive thesis centered on precision medicine and therapeutics that fundamentally change clinical practice.
Every field above is read from the StartupFundraising investor directory — disclosed location, recorded investments and stated focus — and re-checked as filings arrive. Founders pair it with investors in Stockholm when building a target list.
Investors like Bjorn Odlander · Full investor directory · Investor access · Company funding database